Text messages and personal support may reduce pregnancy risks — a trial puts them to the test

NCT ID NCT06510075

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether two types of support — digital health information delivered by text message and guidance from community health workers — can reduce serious complications during pregnancy and childbirth. The study enrolls 400 non-Hispanic Black pregnant individuals who face higher risks due to social and economic disadvantages. Participants are randomly assigned to receive one or both forms of support, and researchers track outcomes like preterm birth, NICU stays, and maternal health events.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Digital health intervention and community health worker support
What this could lead to
If effective, these support strategies could reduce serious pregnancy complications and help address racial inequities in maternal and infant health.
What could go wrong
This is a single-site trial focused on one population, so results may not apply broadly. The interventions are behavioral and may not overcome all social or medical risk factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVERSE BIRTH OUTCOMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Alabama at Birmingham

    RECRUITING

    Birmingham, Alabama, 35233, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.